NCT02411994View on ClinicalTrials.gov

Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria

PHASE3CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Malaria
Interventions
DRUG

Pyronaridine-artesunate

DRUG

Artemether-lumefantrine combination

Trial Locations (1)

30-40305

St. Jude's Clinic, ICIPE, Mbita

All Listed Sponsors
lead

Royal Tropical Institute

OTHER

NCT02411994 - Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria | Biotech Hunter | Biotech Hunter